We are live on ! Find out more
BLCM

Bellicum Pharmaceuticals, Inc.
BLCM

Delisted

BLCM was delisted on the 1st of June, 2023.

Back to rankings

84 hedge funds and large institutions have $216M invested in Bellicum Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 19 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 19

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

13% less funds holding

Funds holding: 96 → 84 (-12)

18% less capital invested

Capital invested by funds: $263M → $216M (-$47M)

36% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 33

86% less call options, than puts

Call options by funds: $354K | Put options by funds: $2.48M

Holders
84
Holders Change
-12
Holders Change %
-12.5%
% of All Funds
2.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
39
Reduced
19
Closed
33
Calls
$354K
Puts
$2.48M
Net Calls
-$2.13M
Net Calls Change
-$789K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.59M
2
JP Morgan Chase
JP Morgan Chase
New York
+$2.83M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.8M
4
NI
Numeric Investors
Massachusetts
+$1.21M
5
Goldman Sachs
Goldman Sachs
New York
+$1.18M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$8.04M
2
KCM
Kennedy Capital Management
Missouri
-$6.53M
3
FCMI
Foresite Capital Management III
California
-$5.78M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$5.12M
5
QF
QVT Financial
New York
-$3.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$947K +$61.9K +499 +7%
TA
27
Teachers Advisors
New York
$928K +$543K +4,372 +122%
MTC
28
McDaniel Terry & Co
Texas
$797K -$97.3K -784 -10%
Citadel Advisors
29
Citadel Advisors
Florida
$759K +$367K +2,956 +83%
VKH
30
Virtu KCG Holdings
New York
$728K +$773K +6,229 New
TCM
31
Tekla Capital Management
Massachusetts
$701K – – –
FCMI
32
Foresite Capital Management II
California
$591K -$676K -5,444 -52%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$562K +$85.6K +690 +17%
FAM
34
Fred Alger Management
New York
$561K -$24.8K -200 -4%
Swiss National Bank
35
Swiss National Bank
Switzerland
$517K – – –
DADC
36
D.A. Davidson & Co
Montana
$474K +$59K +475 +13%
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$474K +$503K +4,056 New
HighTower Advisors
38
HighTower Advisors
Illinois
$448K +$472K +3,801 New
RJA
39
Raymond James & Associates
Florida
$420K +$446K +3,596 New
AllianceBernstein
40
AllianceBernstein
Tennessee
$388K +$171K +1,380 +71%
NIT
41
NumerixS Investment Technologies
British Columbia, Canada
$383K +$407K +3,280 New
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$358K +$90K +725 +31%
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$335K +$356K +2,870 New
FRM
44
Fox Run Management
Connecticut
$328K +$177K +1,427 +103%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$327K +$81.9K +660 +31%
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$261K +$58.1K +468 +27%
Allianz Asset Management
47
Allianz Asset Management
Germany
$240K -$6.21K -50 -2%
DCM
48
DAFNA Capital Management
California
$234K – – –
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$234K +$248K +2,000 New
DMK
50
David M. Knott
$233K +$117K +940 +89%
1
2
3 4 5

BLCM Hedge Fund Activity: Q2 2017 in Review

84 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bellicum Pharmaceuticals, Inc. (BLCM) for Q2 2017, worth a combined $216M — down 18% from $263M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of BLCM and 21 opened new positions — a net loss of 12 holders — while 19 trimmed existing stakes and 39 added.

The largest buyer was BlackRock, adding an estimated $6.59M. The largest seller was Franklin Resources, exiting entirely with an estimated $8.04M sold.

  • 84 institutional investors held Bellicum Pharmaceuticals, Inc. (BLCM) as of Q2 2017, down from 96 in Q1 2017.
  • Funds reported $216M of Bellicum Pharmaceuticals, Inc. stock for Q2 2017, down 18% quarter-over-quarter.
  • 21 funds opened new Bellicum Pharmaceuticals, Inc. positions in Q2 2017 and 33 closed out, a net change of -12 holders.
  • The largest Bellicum Pharmaceuticals, Inc. buyer in Q2 2017 was BlackRock, an estimated $6.59M added.
  • The largest Bellicum Pharmaceuticals, Inc. seller in Q2 2017 was Franklin Resources, an estimated $8.04M sold.

Based on aggregated 13F filings for Q2 2017.